Omattage Mahasha Perera

Omattage Mahasha Perera

Auto-generated profile, based on publicly available information

Omattage Mahasha Perera

Department of Urology Ipswich Hospital Ipswich Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MPMahasha P.J. Perera
Mahasha P.J. Perera
PTPatrick Thomas
Patrick Thomas
Gail RisbridgerGail Risbridger
Gail Risbridger
RTRenea A. Taylor
Renea A. Taylor
AAArun Azad
Arun Azad
IVIan Vela
Ian Vela
Prostate cancer is the most commonly diagnosed solid-organ cancer amongst males worldwide. Metastatic castrate-resistant prostate cancer (mCRPC) is a rapidly fatal end-sequelae of prostate cancer. Therapeutic options for men with mCRPC are limited and are not curative in nature. The recent development of chimeric antigen receptor T-cell (CAR-T) therapy has revolutionised the treatment of treatment-resistant haematological malignancies, and several studies are underway investigating the utility of this technology in the treatment of solid tumours. In this review, we evaluate the current treatment options for men with mCRPC as well as the current landscape of preclinical and clinical trials of CAR-T cell therapy against prostate cancer. We also appraise the various prostate cancer-specific tumour-associated antigens that may be targeted by CAR-T cell technology. Finally, we examine the potential translational barriers of CAR-T cell therapy in solid tumours. Despite preclinical success, preliminary clinical trials in men with prostate cancer have had limited efficacy. Therefore, further clinically translatable preclinical models are required to enhance the understanding of the role of this investigational therapeutic in men with mCRPC. In the era of precision medicine, tailored immunotherapy administered to men in a tumour-agnostic approach provides hope to a group of men who otherwise have few treatment options available.

24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.

13 June 2025 in Anz Journal of Surgery
Verified
Journal Article
Open access
YHYam Ting Ho
Yam Ting Ho
OPOmattage M. Perera
Omattage M. Perera
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
HGHarrison Gregory
Harrison Gregory
HMHugh McMahon
Hugh McMahon
PCPeter J. Coverdale
Peter J. Coverdale
Background: Acute diverticulitis (AD) is a common surgical condition and the Neutrophil‐lymphocyte ratio (NLR) is an emerging biomarker ratio used to guide its management. The aim of this study is to validate and assess the utility of the NLR in AD in the Australian population.Methods: This is a single centre retrospective observational study of patients who presented to the emergency department with the diagnosis of AD between September 2018 and September 2023, in Ipswich, Queensland. One thousand five hundred and forty patients were screened against exclusion/inclusion criteria and 634 patients were available for analysis.Results: The study identified NLR, CRP (C‐reactive protein) and age to be significant coefficients in predicting length of stay (LOS) in regression analysis. NLR (OR1.06, p < 0.001) and CRP (OR1.01, p < 0.001) were significant predictors for surgical management of diverticulitis. NLR was found to be superior predictor of surgical management in ROC analysis (AUC 0.75, sensitivity 65%, specificity 75%, p < 0.001) compared to CRP, but both were equivalent in predicting for diverticulitis severity and percutaneous drainage. Further analysis revealed NLR between those receiving surgery, percutaneous drainage and readmission (One‐way ANOVA) and NLR between modified Hinchey classifications were also significantly different (Mann–Whitney U).Conclusion: In this study, we have further validated the effectiveness of NLR as a diagnostic marker. In particular, NLR is superior to CRP in predicting surgical management. It has also proven useful to predict for LOS, disease severity and percutaneous drainage. NLR usage should be encouraged in the clinical setting as it is simple and effective.

26 January 2026 in Trends in Urology & Men's Health
Verified
Journal Article
Open access
YHYam Ting Ho
Yam Ting Ho
OPOmattage Mahasha Perera
Omattage Mahasha Perera
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
NPNishal Patel
Nishal Patel
AKAkshay Kothari
Akshay Kothari
Persisting small renal stone fragments remain a challenge after conventional renal stone treatment (ESWL or endoscopic treatment). Physical vibration therapy and patient inversion therapy are new techniques developed with the aim of increasing the stone‐free rate (SFR). This study aims to evaluate the efficacy and safety of physical therapy and mechanical percussion in improving SFR after conventional stone surgery. A systematic review meta‐analysis was performed according to the Cochrane Handbook and registered in PROSPERO (CRD42021232954). PubMed, Web of Science, and Scopus databases were searched for manuscripts considering adjunctive stone treatment methods following endoscopic surgery or shock wave lithotripsy, published between 2018 and 2024. Additional inclusion criteria encompassed randomized controlled trials, cohort studies, and case−control studies published in English. Duplicate studies or studies that did not meet the inclusion criteria were excluded. Full manuscripts were reviewed for clinical data. OpenMeta (analyst) was used to perform statistical analysis, and the ROBINS‐I tool was used for risk of bias assessment. Six studies comprising 1026 participants were included. Our study showed that adjuvant therapy (EPVL or PDI) after stone surgery (ESWL or RIRS) significantly increases SFR at 1 week (OR = 0.60, p  < 0.001), 2 weeks (OR = 0.689, p  < 0.001), and at 4 weeks (OR = 0.786, p  < 0.001). Complications did not differ between treatment arms and control groups. The overall risk of bias among studies was low. Adjuvant therapy has been shown to be an effective tool in increasing SFR post‐conventional stone surgery. Further research is necessary to create standardized treatment protocols.

11 September 2026 in Anz Journal of Surgery
Verified
Journal Article
Open access
PDF file
YHYam Ting Ho
Yam Ting Ho
OPOmattage M. Perera
Omattage M. Perera
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
NJNicola Jeffery
Nicola Jeffery
ITIsaac Thangasamy
Isaac Thangasamy
DDDevang Desai
Devang Desai
Objective: To identify trends in the management and prevalence of urethral stricture disease in Australia over a period of two decades: Methods: Databases related to urethral procedures between financial year (FY) 2000/01 and 2022/23 were sourced from Australian Institute of Health & Welfare and Medicare Benefits Scheme. The data include length of stay and procedure counts based on age, gender and procedure type. Nationwide subsidy burden was estimated from Service Australia data. Results: Between FY2000/01 and 2022/23, there is a decreasing trend in urethral procedures performed. We observed a 9% increase in urethroplasty procedures and a 9% decrease in urethral dilatation procedures. Urethral procedures are commonly performed in 70–79 years old, though a rise in urethroplasty in younger patients over time was observed. The ratio of urethroplasty to endoscopic procedures has shifted from 1:13 to 1:5 in the last two decades. The estimated length of stay related to urethral procedures has reduced from 2.1 to 1.4 days. The nationwide subsidy burden between FY2002/03 and 2022/23 has increased from $23 113 to $26 825 per 100 000 persons. Conclusion: Within the last two decades, there is a reduction in urethral procedures performed nationwide; however, among the procedures performed, we observed a rise in urethroplasty and reduction in dilatation procedures. We observed more urethral procedures performed in older males, with a notable increased uptake in urethroplasty in younger patients. This suggests that there is a shift to more sub‐specialised reconstructive surgical techniques for the management of urethral stricture disease within Australia. Finally, the nationwide estimated subsidy burden has increased slightly.